Kanaoka E - Search Results

1

Renoprotective action of a matrix metalloproteinase inhibitor in progressive mesangioproliferative nephritis.

Kuroda T, Masui M, Notoya M, Ito M, Tamura Y, Okamoto H, Kanaoka E, Shinosaki T. Kuroda T, et al. Among authors: kanaoka e. Nephron Extra. 2012 Jan;2(1):133-46. doi: 10.1159/000338801. Epub 2012 May 26. Nephron Extra. 2012. PMID: 22739248 Free PMC article.

2

Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment.

Ohnishi S, Okamura N, Sakamoto S, Hasegawa H, Norikura R, Kanaoka E, Takahashi K, Horie K, Sakamoto K, Baba T. Ohnishi S, et al. Among authors: kanaoka e. Drug Metab Pharmacokinet. 2008;23(4):293-303. doi: 10.2133/dmpk.23.293. Drug Metab Pharmacokinet. 2008. PMID: 18762717 Free article.

3

Continuous release of interleukin-2 from liposomal IL-2 (mixture of interleukin-2 and liposomes) after subcutaneous administration to mice.

Kanaoka E, Takahashi K, Yoshikawa T, Jizomoto H, Nishihara Y, Hirano K. Kanaoka E, et al. Drug Dev Ind Pharm. 2003 Nov;29(10):1149-53. doi: 10.1081/ddc-120025872. Drug Dev Ind Pharm. 2003. PMID: 14677775

4

A significant enhancement of therapeutic effect against hepatic metastases of M5076 in mice by a liposomal interleukin-2 (mixture).

Kanaoka E, Takahashi K, Yoshikawa T, Jizomoto H, Nishihara Y, Uchida N, Maekawa R, Hirano K. Kanaoka E, et al. J Control Release. 2002 Aug 21;82(2-3):183-7. doi: 10.1016/s0168-3659(02)00083-4. J Control Release. 2002. PMID: 12175736

5

A novel and simple type of liposome carrier for recombinant interleukin-2.

Kanaoka E, Takahashi K, Yoshikawa T, Jizomoto H, Nishihara Y, Hirano K. Kanaoka E, et al. J Pharm Pharmacol. 2001 Mar;53(3):295-302. doi: 10.1211/0022357011775523. J Pharm Pharmacol. 2001. PMID: 11291744

6

A new generic column switching system for quantitation in cassette dosing using LC/MS/MS.

Ohkawa T, Ishida Y, Kanaoka E, Takahashi K, Okabe H, Matsumoto T, Nakamoto S, Tamada J, Koike M, Yoshikawa T. Ohkawa T, et al. Among authors: kanaoka e. J Pharm Biomed Anal. 2003 Apr 10;31(6):1089-99. doi: 10.1016/s0731-7085(02)00649-0. J Pharm Biomed Anal. 2003. PMID: 12667925

7

pH-sensitive liposomes composed of tocopherol hemisuccinate and of phosphatidylethanolamine including tocopherol hemisuccinate.

Jizomoto H, Kanaoka E, Hirano K. Jizomoto H, et al. Among authors: kanaoka e. Biochim Biophys Acta. 1994 Aug 4;1213(3):343-8. Biochim Biophys Acta. 1994. PMID: 8049248

8

Stabilization of aerosolized IFN-gamma by liposomes.

Kanaoka E, Nagata S, Hirano K. Kanaoka E, et al. Int J Pharm. 1999 Oct 25;188(2):165-72. doi: 10.1016/s0378-5173(99)00218-5. Int J Pharm. 1999. PMID: 10518672

9

Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design.

Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, Masuda K. Kawakami K, et al. Among authors: kanaoka e. J Control Release. 2002 May 17;81(1-2):65-74. doi: 10.1016/s0168-3659(02)00049-4. J Control Release. 2002. PMID: 11992679

10

Gelatin-acacia microcapsules for trapping micro oil droplets containing lipophilic drugs and ready disintegration in the gastrointestinal tract.

Jizomoto H, Kanaoka E, Sugita K, Hirano K. Jizomoto H, et al. Among authors: kanaoka e. Pharm Res. 1993 Aug;10(8):1115-22. doi: 10.1023/a:1018951814939. Pharm Res. 1993. PMID: 8415395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters